Myriad Genetics, Inc. (FRA:MYD)

Germany · Delayed Price · Currency is EUR

3.580

-0.100 (-2.72%)

Last updated: Feb 23, 2026, 8:22 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Biotechnology	837.60M	753.20M	678.40M	690.60M	-
Biotechnology Growth	11.21%	11.03%	-1.77%	-	-
Total	837.60M	753.20M	678.40M	690.60M	-
Total Growth	11.21%	11.03%	-1.77%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Rest of world	68.10M	81.50M	86.90M	-	42.40M
Rest of world Growth	-16.44%	-6.21%	-	-	0%
United States	769.50M	671.70M	591.50M	-	514.60M
United States Growth	14.56%	13.56%	-	-	-13.69%
Total	837.60M	753.20M	678.40M	-	557.00M
Total Growth	11.21%	11.03%	-	-	-12.78%

Source: S&P Global Market Intelligence.